Acquired Hemophilia Therapeutics Market: Introduction Acquired hemophilia is a rare autoimmune disease, wherein the body’s own immune system destroys blood clotting factor and prevents blood clotting, resulting in excessive bleeding. This is not congenital and develops suddenly due to abnormality insource https://www.openpr.com/news/2459474/acquired-hemophilia-therapeutics-market-qualitative